Why HCA Healthcare (HCA) Shares Are Surging Today - HCA Healthcare (NYSE:HCA)

HCA Healthcare Inc HCA has reported Q2 FY22 revenues of $14.82 billion, compared to $14.43 billion a year ago, beating the consensus of $14.72 billion.
EPS of $4.21, lower than the $4.37 reported a year ago, surpasses the estimate of $3.70.
Net income fell from $1.45 billion to $1.15 billion.
"Many aspects of our business were positive considering the challenges we faced with the labor market and other inflationary pressures on costs," said Sam Hazen, CEO of HCA Healthcare.
Same facility admissions decreased 1.2% Y/Y, and equivalent admissions increased 0.5%.
Same facility revenue per equivalent admission increased 3.5%.
Same facility emergency room visits increased by 7.3%, inpatient surgeries declined 2.3%, and outpatient surgeries declined 1.4%.
Adjusted EBITDA totaled $3.04 billion, compared to $3.22 billion in Q2 FY21.
Dividend: HCA Healthcare declared a quarterly cash dividend of $0.56 per share, payable on September 30, at the record date of September 16.
Price Action: HCA shares are up 13.24% at $205.31 during the premarket session on the last check Friday.

Momentum79.45

Growth45.82

QualityNot Available

Value35.99

Short

Medium

Long

Investors Cheer Better-Than-Expected HCA Healthcare's Q2 Earnings